Fujifilm Diosynth Biotechnologies has taken a significant step toward bolstering its microbial production capabilities with the inauguration of a new microbial fermentation manufacturing facility in Billingham, UK. As a leading contract development and manufacturing organization (CDMO), the company
Tanvex BioPharma USA, Inc., a frontrunner in biologics development, has made significant strides by securing FDA approval for NYPOZI (filgrastim-txid) and advancing its Biologics License Application (BLA) for TX-05. These milestones underscore the company’s unwavering commitment to delivering h
Novo Nordisk has announced a significant expansion of its manufacturing capabilities at its Køge site in Denmark, aiming to address the soaring global demand for its diabetes and obesity treatments. As one of the leading pharmaceutical companies worldwide, this move underlines Novo Nordisk's
The biopharmaceutical excipients market has been witnessing rapid advancements, paving the way for significant evolution by 2029. These excipients, which are vital components of drug formulations, play crucial roles in enhancing drug efficacy, stability, and delivery. As the market grows, driven by
In the rapidly evolving field of biopharmaceuticals, the quest for high-quality biologics hinges on the ability to thoroughly analyze and understand complex protein structures. The critical role of proteomics—a branch of biochemistry focused on the study of proteins—cannot be overstated. As demand f
In an ambitious move to optimize essential quality management and operational processes, Quest Nutra Pharma has partnered with Kissflow to harness the power of its Low-Code platform. This collaboration marks a significant step toward increased efficiency and accuracy in the field of nutraceutical
